Recent regulatory filings reveal a split in institutional sentiment toward Trustmark Corporation (TRMK) shares during Q1. While Vanguard Group Inc. reduced its stake by 1.7%, selling 111,071 shares, Charles Schwab Investment Management Inc. took the opposite approach. The latter boosted its position by a significant 11.1%, acquiring an additional 99,134 shares. In a smaller move, LPL Financial LLC increased its holdings by 0.6%, adding 415 shares to its portfolio. These contrasting trades highlight a clear divergence in strategy among the bank’s largest shareholders.
Strong Earnings and Dividend Declaration
The company’s latest quarterly performance exceeded market forecasts. Trustmark reported earnings per share (EPS) of $0.92, soundly beating the consensus estimate of $0.86. Revenue for the period reached $203.44 million, also coming in above the projected $200.35 million.
In a separate announcement, the board declared a quarterly cash dividend. Shareholders of record will receive a payment of $0.24 per share on September 15. This distribution equates to an annualized dividend of $0.96 and represents a payout ratio of 26.97%.
Should investors sell immediately? Or is it worth buying Trustmark?
Key Valuation Metrics
- Market Capitalization: $2.33 billion
- P/E Ratio: 10.83
- Beta: 0.70
- 50-Day Moving Average: $37.09
- 200-Day Moving Average: $35.60
The stock has been trading within a defined range over the past year, with a 52-week high of $40.73 and a low of $29.77, indicating a period of consolidation.
Analyst Sentiment and Price Targets
Market researchers maintain a cautiously optimistic stance. The average price target currently sits at $41.00, accompanied by a general “Hold” recommendation. Individual firms have been adjusting their outlooks: DA Davidson raised its target to $43.00 while reiterating a Neutral rating, and Hovde Group lifted its target to $41.00. Conversely, Keefe, Bruyette & Woods reduced its target from $45.00 to $43.00, though it maintained an “Outperform” rating on the stock.
Operational Headwinds and Insider Activity
Despite achieving a regulatory milestone by converting its subsidiary to a Mississippi-chartered bank, Trustmark faces ongoing operational challenges. The company is contending with flat non-interest income and rising operational expenses. In a notable transaction, Director Eduardo Marcelo L sold 700 shares yesterday—a move that investors often scrutinize for signals about internal confidence.
Ad
Trustmark Stock: Buy or Sell?! New Trustmark Analysis from February 7 delivers the answer:
The latest Trustmark figures speak for themselves: Urgent action needed for Trustmark investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.
Trustmark: Buy or sell? Read more here...
